Jashvik Capital

Jashvik Capital, a Mumbai, India-based mid-market private equity firm, focuses on investing in profitable, high-growth businesses within the healthcare and consumer sectors. The firm targets investments of $10-50 million per company, aiming to drive transformative growth alongside founders. Its maiden fund, launched in July 2024, targets a corpus of $350 million, with a hard cap of $400 million. Jashvik Capital has already deployed capital, including a $25 million investment in Bengaluru-based medtech firm Dolphin Sutures in June 2024, and plans to acquire over a 50% stake in a Hyderabad-based eye care chain. Key areas of interest span pharma, medtech, eye care, QSR, and women's brands. Jashvik Capital was founded in 2022 by Naresh Patwari. Its business model centers on raises private equity funds to invest $10-50 million in profitable businesses growing over 18% annually, first fund targets $350 million corpus.

Jashvik Capital is a mid-market private equity firm founded in 2022 and based in Mumbai, India, focused on investing alongside founders of profitable, growing businesses primarily in the healthcare, pharma, consumer, food, and consumption-linked sectors[1][3][6]. Their mission is to deliver top-quartile returns with a value mindset by partnering with high-quality companies that have strong competitive advantages and large addressable markets, supporting transformative growth agendas to create significant medium-term value[1][2]. They emphasize ESG (environmental, social, and governance) performance improvement and aim to be deeply trusted partners to founders, helping businesses become more resilient, innovative, and hyper-competitive[1][2].

Jashvik Capital’s investment philosophy centers on profitable growth with a value mindset, targeting free cash flow positive companies with strong intellectual property or other competitive moats[1]. They leverage deep sector expertise and networks to accelerate growth and strategic value creation, particularly in healthcare and consumer sectors[1][3]. Their impact on the startup and growth-stage ecosystem includes enabling expansion in underserved markets, such as specialized healthcare services like eye care, where they have invested in chains like Smart Vision Eye Specialities and medtech firms like Futura Surgical[3]. This focus helps professionalize and scale mid-market companies in India, contributing to sectoral growth and innovation.

Origin Story:
Jashvik Capital was founded in 2022 by Naresh Patwari, who serves as Managing Partner, along with a leadership team with decades of experience in investing and operating businesses[1][6]. The firm evolved with a clear focus on building mid-market champions in India by investing alongside exceptional founders and management teams. Their approach grew from recognizing the need for patient capital and strategic partnership in mid-sized profitable businesses that have the potential for transformative growth but require operational and governance support[1].

Core Differentiators:
- Unique Investment Model: Focus on profitable, free cash flow positive businesses with strong IP and competitive advantages, investing alongside founders rather than replacing them[1].
- Sector Expertise: Deep knowledge and networks in healthcare, pharma, consumer, and food sectors to add strategic value and accelerate growth[1][3].
- Track Record: Leadership team with decades-long experience driving value in mid-market companies, demonstrated by investments in healthcare chains and medtech startups[1][3].
- Operating Support: Provides governance frameworks and operational support while allowing management to retain strategic control and imprint their growth vision[1].

Role in the Broader Tech Landscape:
Jashvik Capital rides the trend of increasing specialization and professionalization in India’s mid-market private equity space, particularly in healthcare and consumer sectors that are poised for rapid growth due to rising demand and underserved markets[3]. The timing is favorable given India’s expanding healthcare infrastructure needs and growing consumer markets. Their investments in specialized healthcare services reflect a broader shift toward focused, high-quality care centers over general multi-specialty hospitals, aligning with global trends in healthcare delivery[3]. By supporting these companies, Jashvik Capital influences the ecosystem by enabling scale, innovation, and improved service quality.

Quick Take & Future Outlook:
Looking ahead, Jashvik Capital is positioned to expand its footprint, particularly in South India, as evidenced by recent investments aimed at regional growth[3]. The firm will likely continue leveraging sector expertise to identify and grow mid-market champions, riding trends such as healthcare specialization, consumer market expansion, and ESG integration. Their influence may grow as they deepen partnerships with founders and contribute to building resilient, innovative companies that shape India’s evolving economic landscape. This aligns with their founding vision of creating a world-class India-focused investment firm delivering consistent top-quartile returns while making a positive societal impact[2].